Tg(Myod1-BCL2)1Jbm
Transgene Detail
|
|
| Symbol: |
Tg(Myod1-BCL2)1Jbm |
| Name: |
transgene insertion 1, Jeffrey Boone Miller |
| MGI ID: |
MGI:3789480 |
| Synonyms: |
pMyoD-hBcl-2 |
| Transgene: |
Tg(Myod1-BCL2)1Jbm Location: unknown
|
| Alliance: |
Tg(Myod1-BCL2)1Jbm page
|
|
|
|
| Transgene Type: |
|
Transgenic (Inserted expressed sequence) |
| Mutation: |
|
Insertion
|
| |
|
Tg(Myod1-BCL2)1Jbm expresses
1 gene
Transgene expresses:
| Organism |
Expressed Gene |
Homolog in Mouse |
Note |
| human |
BCL2 (596) |
|
|
|
| |
|
Mutation details: The sequence for human BCL2 was placed under the control of an opproximately 7kb fragment of the mouse myogenic differentiation 1 promoter.
(J:94431)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
| Original: |
J:94431 Girgenrath M, et al., Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy. J Clin Invest. 2004 Dec;114(11):1635-9 |
| All: |
4 reference(s) |
|
Analysis Tools
